Clinical Trials Browser

Phase NA × ponatinib × Gynecologic × Clear all

NCT01888562 2015-12-18

Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma

Phase NA Withdrawn

Endometrial Neoplasms